CD4 and cutaneous mastocytosis: A proportion of CM cases are preventable, as was shown in an observational study conducted in Uganda: among ART-naïve, HIV-infected patients, with a CD4 T-cell count <100 cells/μL, the number needed to screen to prevent one case of CM was 11.3, and the number needed to screen to prevent one death was 15.9 (8).